Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Heaney

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Blood|March 2, 2013
Saving orphans: BRAF targeting of histiocytosisMark L Heaney
European Journal of Haematology|March 18, 2015
Zeroing in on cereblonMark L Heaney
The Lancet. Haematology|December 31, 2021
Can the treatment of myeloproliferative neoplasms be both good and bad for you?Mark L Heaney
Clinical Advances in Hematology & Oncology : H&O|October 31, 2014
Sequencing treatment in chronic myeloid leukemia: the first choice may be the hardestMark L Heaney
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|December 8, 1996
Outpatient infusion clinics: a strategy for the successful management of advanced heart failureL Heaney, C Antonio
Current Hematologic Malignancy Reports|April 11, 2013
Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapyMark L Heaney, Gabriela Soriano
Journal of Toxicology and Environmental Health. Part A|November 22, 2000
Review of the Cox hematotoxicity modelM L Heaney, S D Nimer
Expert Review of Anticancer Therapy|February 17, 2021
Glasdegib in newly diagnosed acute myeloid leukemiaShawn M Sarkaria, Mark L Heaney
Blood|October 1, 1993
Soluble hormone receptorsM L Heaney, D W Golde
Current Oncology Reports|December 21, 2000
Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemiaM L Heaney, D W Golde,
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Blood|March 2, 2013
Saving orphans: BRAF targeting of histiocytosisMark L Heaney
European Journal of Haematology|March 18, 2015
Zeroing in on cereblonMark L Heaney
The Lancet. Haematology|December 31, 2021
Can the treatment of myeloproliferative neoplasms be both good and bad for you?Mark L Heaney
Clinical Advances in Hematology & Oncology : H&O|October 31, 2014
Sequencing treatment in chronic myeloid leukemia: the first choice may be the hardestMark L Heaney
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|December 8, 1996
Outpatient infusion clinics: a strategy for the successful management of advanced heart failureL Heaney, C Antonio
Current Hematologic Malignancy Reports|April 11, 2013
Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapyMark L Heaney, Gabriela Soriano
Journal of Toxicology and Environmental Health. Part A|November 22, 2000
Review of the Cox hematotoxicity modelM L Heaney, S D Nimer
Expert Review of Anticancer Therapy|February 17, 2021
Glasdegib in newly diagnosed acute myeloid leukemiaShawn M Sarkaria, Mark L Heaney
Blood|October 1, 1993
Soluble hormone receptorsM L Heaney, D W Golde
Current Oncology Reports|December 21, 2000
Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemiaM L Heaney, D W Golde,
Pageof 9